These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1471076)

  • 1. DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.
    Malyszko J; Malyszko JS; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1992 Nov; 68(3):303-8. PubMed ID: 1471076
    [No Abstract]   [Full Text] [Related]  

  • 2. A partial role of serotonin in normalization of the bleeding time by DDAVP in uraemic rats.
    Pietraszek M; Azzadin A; Buczko W; Malyszko J; Mysliwiec M
    Thromb Haemost; 1992 Nov; 68(5):625. PubMed ID: 1455414
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possible role of serotonin in hemostatic the mechanism of action of desmopressin (DDAVP) in patients with uremia].
    Małyszko J; Małyszko J; Pietraszek M; Azzadin A; Myśliwiec M; Buczko W
    Pol Arch Med Wewn; 1993 Aug; 90(2):105-11. PubMed ID: 8247943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of desmopressin (DDAVP) on protein C and protein C inhibitors in uremia.
    Akpolat T; Ozdemir O; Arik N; Demirkan F; Sungur C; Ozcebe O; Dündar S; Yasavul U; Turgan C; Kirazli S
    Nephron; 1993; 64(2):232-4. PubMed ID: 8321356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin induces decrease in platelet serotonin content in uremia.
    Małyszko J; Pietraszek MH; Azzadin A; Buczko W; Myśliwiec M
    Thromb Haemost; 1989 Jun; 61(3):537. PubMed ID: 2799766
    [No Abstract]   [Full Text] [Related]  

  • 6. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
    Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
    Yang X; Disa J; Rao AK
    Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Knoers N; Brommer EJ; Willems H; van Oost BA; Monnens LA
    Nephron; 1990; 54(4):322-6. PubMed ID: 2109264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin-induced improvement in bleeding times in chronic renal failure patients correlates with platelet serotonin uptake and ATP release.
    Soslau G; Schwartz AB; Putatunda B; Conroy JD; Parker J; Abel RF; Brodsky I
    Am J Med Sci; 1990 Dec; 300(6):372-9. PubMed ID: 2264575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion.
    Keber D; Stegnar M; Kluft C
    Thromb Haemost; 1990 Feb; 63(1):72-5. PubMed ID: 2111049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine and DDAVP induced rise in tissue plasminogen activator.
    Grant PJ; Wiles PG; Davies JA; Prentice CR
    Thromb Haemost; 1988 Oct; 60(2):342. PubMed ID: 3146147
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of venous occlusion on the PAI and antiplasmins release from platelets.
    Woods AI; Nadra CA; Lazzari MA
    Thromb Res; 1989 Nov; 56(3):491-5. PubMed ID: 2515615
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease.
    Sultan Y; Loyer F; Venot A
    Nouv Rev Fr Hematol (1978); 1992; 34(1):55-60. PubMed ID: 1523100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.
    Lee HK; Kim YJ; Jeong JU; Park JS; Chi HS; Kim SB
    Nephron Clin Pract; 2010; 114(4):c248-52. PubMed ID: 20090366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal homeostasis of fibrinolysis in nephrogenic diabetes insipidus in spite of defective V2- receptor-mediated responses of tissue plasminogen activator release.
    Brommer EJ; Brink H; Derkx FH; Schalekamp MA; Stibbe J
    Eur J Clin Invest; 1990 Feb; 20(1):72-8. PubMed ID: 2138555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
    Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of factor VIII and tissue plasminogen activator can not be blocked by specific antagonists to vasopressin.
    Vilhardt H; Barth T
    J Recept Res; 1991; 11(1-4):239-45. PubMed ID: 1909360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.